Screening and therapy for causes of immune fetal hydrops have decreased it's incidence, making nonimmune fetal hydrops and its causes more important. From 1/80 to 6/95, 105 cases of fetal hydrops were identified (23 weeks to term). In 79 (75%), the cause was identified. There were 16 cases of immune fetal hydrops, 7 (44%) died; 15 cases had atrial tachycardia, 2 (13%) died; 7 had structural heart disease, 6 (86%) died; 5 had renal/urolgoic disease, 3(60%) died; 4 had cytomegalovirus, 2 (50%) died; 4 had chromosomal abnormalities (1 also had significant structural heart disease), 0 died; 3 had metabolic disease, 2 (67%) died; 3 had hepatitis, 2 (67%) died; 3 had syndromes, 3 (100%) died; 2 had cystic adenomatoid malformation, 1 died; 2 had twin-twin transfusion, 1 twin died; 2 had diaphragmatic hernia, 2 died. There was one case each of fetal-maternal transfusion [alive (A)]; sacrococcygial teratoma [died (D)]; osteogenesis imperfecta (A); pulmonary arteriosclerosis(D); cystic fibrosis (A); erythrophagacytic lymphohistiocytosis (D); streptococcal sepsis (D). Three cases had unknown viral infection, 1 died. There were 26 of unknown etiology, 12 (46%) died.
Three cases were found to have nuclear inclusions consistent with parvovirus at autopsy. Only 1 had been tested for parvovirus. In 2 there was significant cardiac hypertrophy both echocardiographically and at autopsy.
Conclusions: 1) Fetal hydrops due to structural heart disease has a high mortality (86%) whereas mortality due to supraventricular tachycardia is low(13%); 2) Parvovirus induced anemia can lead to heart failure but parvovirus also appears to directly effect cardiac cells and their function; 3) Cardiac hypertrophy on echocardiogram may indicate the presence of parvovirus infection; 4) Parvovirus was tested for in < 10% of the fetal hydrops cases.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nguyen, H., Rice, M., Stenzel, P. et al. PARVOVIRUS CAUSING CARDIAC HYPERTROPHY. 1383. Pediatr Res 39 (Suppl 4), 233 (1996). https://doi.org/10.1203/00006450-199604001-01406
Issue Date:
DOI: https://doi.org/10.1203/00006450-199604001-01406